Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

PHASE2RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
EmphysemaHIV
Interventions
DRUG

Doxycycline

Doxycycline 100 mg orally twice a day.

DRUG

Placebo

Matching placebo orally twice a day.

Trial Locations (21)

10065

RECRUITING

Weill Cornell Medicine, New York

11203

TERMINATED

SUNY Downstate Medical School, Brooklyn

15261

TERMINATED

University of Pittsburgh, Pittsburgh

19140

RECRUITING

Temple University, Philadelphia

21287

RECRUITING

Johns Hopkins University School of Medicine, Baltimore

27514

TERMINATED

University of North Carolina, Chapel Hill

27704

RECRUITING

Duke University School of Medicine, Durham

30329

RECRUITING

Emory University, Atlanta

33136

RECRUITING

Miami University, Miami

35233

RECRUITING

University of Alabama at Birmingham, Birmingham

43210

RECRUITING

Ohio State University, Columbus

44106

RECRUITING

Case Western University, Cleveland

45267

RECRUITING

University of Cincinnati College of Medicine, Cincinnati

63110

RECRUITING

Washington University School of Medicine, St Louis

70112

RECRUITING

Tulane University, New Orleans

77030

RECRUITING

University of Texas, McGovern Medical School, Houston

80045

NOT_YET_RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

90095

RECRUITING

University of California Los Angeles, Los Angeles

92103

RECRUITING

University of California San Diego, San Diego

98104

RECRUITING

University of Washington, Seattle

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University of California, Los Angeles

OTHER

collaborator

University of Iowa

OTHER

collaborator

University of Michigan

OTHER

lead

Weill Medical College of Cornell University

OTHER